Investors – Medarion Pharma – Better Supportive Care

Partners & Investors

Supporting the development of SkiNFiDAR® and DIAFAST®

SkiNFiDAR® and DIAFAST® are currently available in Iran. Medarion Pharma plans to further develop and improve both products for the UK market using advanced formulation, manufacturing and quality-control technologies.

Our work will include product evaluation, regulatory planning and the development of suitable UK manufacturing arrangements. The products are not currently manufactured, approved or available for sale in the UK.

We welcome enquiries from organisations and investors interested in supporting the development of these products for the UK market.